2 Information about pentosan polysulfate sodium
|
Marketing authorisation indication |
Pentosan polysulfate sodium (Elmiron, Consilient Health) has a marketing authorisation for treating 'bladder pain syndrome characterised by either glomerulations or Hunner's lesions in adults with moderate to severe pain, urgency and frequency of micturition'. |
|---|---|
|
Dosage in the marketing authorisation |
300 mg/day taken as 1 × 100-mg capsule orally 3 times daily. Treatment is stopped if no improvement is reached 6 months after starting treatment. In people whose condition responds, treatment should be continued as long as the response is maintained. Response to treatment should be reassessed every 6 months. |
|
Price |
A pack of 90 capsules (100 mg each) costs £450. The company has a commercial arrangement. This makes pentosan polysulfate sodium available to the NHS with a discount. The size of the discount is commercial in confidence. It is the company's responsibility to let relevant NHS organisations know details of the discount. |